Aerie Pharma Revenue, Profits - AERI Quarterly Income Statement

Add to My Stocks
$56.55 $0.4 (0.71%) AERI stock closing price Sep 18, 2018 (Closing)

AERI stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Aerie Pharma stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from - to 2.42M and how operating and non operating activities have impacted the AERI stock. The Aerie Pharma profit and loss statement for 2018 Q2 shows a net profit of $-55.02M. Profits for last year was $-40.7M. Apart from this an investor should also check Aerie Pharma assets and Aerie Pharma free cash flow.

View and download details of revenue and profits for Aerie Pharma for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Aerie Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Aerie Pharma Gross Profit
Research & Development Expense18.16M12.97M38.11M12.4M10.61M10.95M14.11M12.68M13.3M12.3M
Selling General & Admin Expense39.89M27.82M22.22M19.77M17.15M14.47M14.67M10.62M9.38M9.8M
Income Before Depreciation Depletion Amortization-55.68M-40.79M-60.33M-32.18M-27.76M-25.42M-28.76M-23.31M-22.69M-22.11M
Depreciation Depletion Amortization----------
Non Operating Income---0.11M-0.14M-0.61M-0.31M-0.51M-0.46M-0.48M-0.54M
Interest Expense----------
Aerie Pharma Pretax Income
Provision for Income Taxes---1.87M-------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-55.02M-40.7M-58.51M-32.37M-28.43M-25.79M-29.32M-23.81M-23.22M-22.7M
Extraordinary Items & Discontinued Operations----------
Aerie Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS39.21M38.6M36.49M36.21M34.78M33.78M33.61M29.38M26.77M26.72M
Average Shares used to compute Basic EPS39.21M38.6M36.49M36.21M34.78M33.78M33.61M29.38M26.77M26.72M
Income Before Nonrecurring Items-55.02M-40.7M-50.51M-32.37M-28.43M-25.79M-29.32M-23.81M-23.22M-22.7M
Income from Nonrecurring Items---8.01M-------
Aerie Pharma Earnings Per Share Basic Net
Aerie Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-1.40-1.05-1.38-0.89-0.82-0.76-0.87-0.81-0.87-0.85
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing Aerie Pharma stock analysis are:

  • Topline: A growing topline, as seen from the Aerie Pharma revenue chart, as is the case with Aerie Pharma indicates a growing business. One needs to compare the QoQ topline or sales growth of AERI stock with its peers like USNA stock and IRWD stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-55.02M for Aerie Pharma for 2018 Q2. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the AERI income statement, one can check the Aerie Pharma historical stock prices to check how the price has moved with time.

Aerie Pharma Income Statement - Key Financial Ratios